Industrial chain: the upstream caprolactam continues its weak operation, the raw material pure benzene is still in the downstream channel, and the cost support is insufficient. Some enterprise devices were restarted, and the supply increased. The downstream market is light, and the demand side has not improved. Under the dual pressure of cost and demand, caprolactam is expected to continue its weak downward operation.

　　The price of upstream caprolactam has fallen recently, and the cost side support of PA6 has been greatly weakened. The overall operating rate of domestic PA6 polymerization plants is more than 60%, the spot price falls upstream, and the profitability of polymerization plants is general. In terms of demand, at present, the inventory position of PA6 of downstream users is acceptable, the purchase intention is not high, and there is a lot of wait-and-see atmosphere in the venue.

　　SunSirs analysts believe that: the spot price of PA6 continues to decline, caprolactam continues to decline, weakening the cost of PA6, weak terminal demand, poor on-site transactions, buyers’ wait-and-see and other falling emotions increase. It is expected that the spot price of PA6 in China may still fall slightly in the short term.